Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

ALUDWIG can help standardize female hair loss assessment from a single image.

More severe hair loss worsens quality of life in men.

The document suggests using a topical Vitamin D treatment for hair loss rather than oral supplements and calls for more research.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Vitamin D may help with certain types of hair loss in women.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

Hair loss can cause anxiety and depression, especially in young, single women, and early psychological support is important.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Women with Frontal Fibrosing Alopecia have more wrinkles near their ears than similar aged women without the condition.

Androgenetic alopecia severity does not affect COVID-19 severity.

Portuguese WAA-QoL questionnaire validated; FPHL severity, schooling, and phototypes affect patients' quality of life.

Mental health issues affect adaptation in alopecia patients more than the cause of hair loss.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Lower hardiness and resilience in mixed alopecia patients may predict more psychological distress.

Alopecia areata significantly affects mental health, especially in women and those with severe cases.

Hairpieces improve quality of life for women with hair loss.

Low-dose Minoxidil combined with Spironolactone helps reduce hair loss and improve hair density in women, with some mild side effects.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Men with severe hair loss may have poorer sperm quality.

Hair loss from genetics and hormones can be treated with drugs or surgery.